TABLE 1.
Model | How Model Is Created | Selected References |
---|---|---|
CRH/stress | CRH i.p. | 10,12,13,16 |
Betamethasone/NMDA | Betamethasone i.p. to dam on G15, followed by NMDA i.p. to offspring on P15 | 18,19,21 |
TTX | TTX i.c. infusion by osmotic pump for 28 days, beginning on P10 | 28 |
Multiple-hit | Doxorubicin i.c.v. and lipopolysaccharide i.c. on P3, followed by p-chlorophenylalanine i.p. on P5 | 31; A. Galanopoulou, MD, PhD, personal communication (December 2008) |
ARX knockout | Targeted deletion of ARX gene from cortical interneurons | 41; E. Marsh, MD, PhD, and A. Brooks-Kayal, MD, personal communication (January 2009) |
Down syndrome | GABAB receptor agonists i.p. to Ts65Dn mice | 45,46 |
CRH, corticotropin-releasing hormone; i.p., intraperitoneal; G, gestational day; P, postnatal day; i.c., intracerebrally; i.c.v., intracerebroventricularly; ARX, Aristaless-related homeobox.